Biospecimen complexity - The next challenge for cancer research biobanks?

Clinical Cancer Research

Volumn 23, Issue 4, 2017, Pages 894-898

  Watson, Peter H ^a,b  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FORMALDEHYDE; PARAFFIN;

BIOBANK; CANCER RESEARCH; EMBEDDING; FINANCIAL MANAGEMENT; FROZEN SECTION; HUMAN; INFORMATION PROCESSING; INFORMED CONSENT; LONGITUDINAL STUDY; MEDICAL LITERATURE; QUALITY CONTROL; REPRODUCIBILITY; REVIEW; STANDARDIZATION; SYSTEMATIC REVIEW; TISSUE FIXATION; TISSUE PRESERVATION; GENETICS; MEDICAL RESEARCH; MEDLINE; NEOPLASM; PATHOLOGY; SPECIMEN HANDLING; STANDARDS; TRANSLATIONAL RESEARCH;

BIOLOGICAL SPECIMEN BANKS; BIOMEDICAL RESEARCH; HUMANS; NEOPLASMS; PUBMED; SPECIMEN HANDLING; TRANSLATIONAL MEDICAL RESEARCH;

EID: 85012874777     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-16-1406     Document Type: Review

References (34)

1. Hughes SE, Barnes RO, Watson PH. Biospecimen use in cancer research over two decades. Biopreserv Biobank 2010;8:89-97.
2. Rogers J, Carolin T, Vaught J, Compton C. Biobankonomics: a taxonomy for evaluating the economic benefits of standardized centralized human biobanking for translational research. J Natl Cancer Inst Monogr 2011;2011:32-8.
3. Bell WC, Sexton KC, Grizzle WE. How to efficiently obtain human tissues to support specific biomedical research projects. Cancer Epidemiol Biomark Prev 2009;18:1676-9.
4. Grizzle WE. A critical need for increased understanding of the use of human tissuesin biomedical research. J Cancer Sci Ther 2012;4:16-7.
5. Vaught J, Rogers J, Myers K, Lim MD, Lockhart N, Moore H, et al. An NCI perspective on creating sustainable biospecimen resources. J Natl Cancer Inst Monogr 2011;2011:1-7.
6. Watson PH, Nussbeck SY, Carter C, O'Donoghue S, Cheah S, Matzke LAM, et al. A framework for biobank sustainability. Biopreserv Biobank 2014;12:60-8.
7. Castillo-Pelayo T, Babinszky S, LeBlanc J, Watson PH. The importance of biobanking in cancer research. Biopreserv Biobank 2015;13:172-7.
8. Scudellari M. Biobank managers bemoan underuse of collected samples. Nat Med 2013;19:253-253.
9. Katsnelson A. Momentum grows to make "personalized" medicine more "precise." Nat Med 2013;19:249.
10. Watson PH. Biobank classification: communicating biorepository diversity. Biopreserv Biobank 2014;12:163-4.
11. Engel KB, Vaught J, Moore HM. National cancer institute biospecimen evidence-based practices: a novel approach to pre-analytical standardization. Biopreserv Biobank 2014;12:148-50.
12. Barnes RO, Parisien M, Murphy LC, Watson PH. Influence of evolution in tumor biobanking on the interpretation of translational research. Cancer Epidemiol Biomark Prev 2008;17:3344-50.
13. Boyd N, Dancey JE, Gilks CB, Huntsman DG. Rare cancers: a sea of opportunity. Lancet Oncol 2016;17:e52-61.
14. Cole A, Cheah S, Dee S, Hughes S, Watson PH. Biospecimen use correlates with emerging techniques in cancer research: impact on planning future biobanks. Biopreserv Biobank 2012;10:518-25.
15. Braun L, Lesperance M, Mes-Massons A-M, Tsao MS, Watson PH. Individual investigator profiles of biospecimen use in cancer research. Biopreserv Biobank 2014;12:192-8.
16. de Bruin EC, McGranahan N, Mitter R, Salm M, Wedge DC, Yates L, et al. Spatial and temporal diversity in genomic instability processes defines lung cancer evolution. Science 2014;346:251-6.
17. Murtaza M, Dawson SJ, Pogrebniak K, Rueda OM, Provenzano E, Grant J, et al. Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer. Nat Commun 2015;6:8760.
18. Aparicio S, Caldas C. The implications of clonal genome evolution for cancer medicine. N Engl J Med 2013;368:842-51.
19. Simeon-Dubach D, Henderson MK. Sustainability in biobanking. Biopreserv Biobank 2014;12:287-91.
20. Merino-Martinez R, Norlin L, van Enckevort D, Anton G, Schuffenhauer S, Silander K, et al. Toward global biobank integration by implementation of the minimum information about biobank data sharing (MIABIS 2.0 Core). Biopreserv Biobank 2016;14:298-306.
21. Matzke EAM, O'Donoghue S, Barnes RO, Daudt H, Cheah S, Suggitt A, et al. Certification for biobanks: the program developed by the canadian tumour repository network (CTRNet). Biopreserv Biobank 2012;10:426-32.
22. Carter A, Betsou F. Quality assurance in cancer biobanking. Biopreserv Biobank 2011;9:157-63.
23. Grizzle WE, Gunter EW, Sexton KC, Bell WC. Quality management of biorepositories. Biopreserv Biobank 2015;13:183-94.
24. Moore HM, Kelly A, Jewell SD, McShane LM, Clark DP, Greenspan R, et al. Biospecimen reporting for improved study quality. Biopreserv Biobank 2011;9:57-70.
25. Vaught J, Rogers J, Carolin T, Compton C. Biobankonomics: developing a sustainable business model approach for the formation of a human tissue biobank. J Natl Cancer Inst Monogr 2011;2011:24-31.
26. Henderson M, Simeon-Dubach D, Albert M. Finding the path to biobank sustainability through sound business planning. Biopreserv Biobank 2015;13:385-6.
27. Odeh H, Miranda L, Rao A, Vaught J, Greenman H, McLean J, et al. The biobank economic modeling tool (BEMT): online financial planning to facilitate biobank sustainability. Biopreserv Biobank 2015;13:421-9.
28. Matzke L, Dee S, Bartlett J, Damaraju S, Graham K, Johnston R, et al. A practical tool for modeling biospecimen user fees. Biopreserv Biobank 2014;12:234-9.
29. Meredith AJ, Slotty A, Matzke L, Babinszky S, Watson PH. A model to estimate frozen tissue collection targets in biobanks to support cancer research. Biopreserv Biobank 2015;13:356-62.
30. Cheah S, O'Donoghue S, Daudt H, Dee S, LeBlanc J, Braun L, et al. Permission to contact (PTC) - a strategy to enhance patient engagement in translational research. Biopreserv Biobank 2013;11:245-52.
31. LeBlanc J, Dee S, Braun L, Daudt H, Cheah S, Watson PH. Impact of a permission to contact (PTC) platform on biobank enrollment and efficiency. Biopreserv Biobank 2013;11:144-8.
32. Kaye J, Whitley EA, Lund D, Morrison M, Teare H, Melham K. Dynamic consent: a patient interface for twenty-first century research networks. Eur J Hum Genet 2015;23:141-6.
33. O'Doherty KC, Burgess MM, Edwards K, Gallagher RP, Hawkins AK, Kaye J, et al. From consent to institutions: designing adaptive governance for genomic biobanks. Soc Sci Med 2011;73:367-74.
34. Freedman LP, Inglese J. The increasing urgency for standards in basic biologic research. Cancer Res 2014;74:4024-9.